The smart Trick of Healthcare News That Nobody is Discussing
Novo CEO pressed by Senate to cut selling prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would look at new talks with insurers about the listing rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Elevance lowers steerage on ‘unprecedented